Markets.com Logo

SRPT

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    19.3955$
  • Previous Close
    20.254$
  • 52 Week Change
    131.31$
  • Day Range
    -0.86$
  • 52 Week High/Low
    10.415$ - 141.72$
  • Dividend Per Share
    --
  • Market cap
    2 011 M$
  • EPS
    2.02
  • Beta
    0.455
  • Volume
    --

About

SRPT.US represents Sarepta Therapeutics Inc., a commercial-stage biopharmaceutical company focused on precision genetic medicine for rare diseases. The company's primary focus is on developing and marketing therapies for Duchenne muscular dystrophy (DMD), a genetic disorder that primarily affects boys. Sarepta has multiple approved therapies for DMD and a robust pipeline of gene therapy and RNA-based programs targeting various genetic mutations and other neuromuscular diseases. The company's financial performance and stock price are influenced by clinical trial results, regulatory approvals, sales of its DMD therapies, and advancements in its research and development pipeline.

The Hormuz Dilemma: Allies Face a Thorny Choice Over Oil Security and International Law

Noah Lee|--

Iran Conflict Fuels Oil Surge, Threatening US Growth and Inflation, Delaying Fed Rate Cuts

Liam James|--

Federal Reserve Holds Rates Steady, Dot Plot Signals Gradual Future Cuts Amid Economic Uncertainty

Emma Rose|--
Social media stock analysis: Why Meta Platforms (META) stock is falling today?

Social media stock analysis: Why Meta Platforms (META) stock is falling today?

Ghko B|--

Who Controls the Strait of Hormuz: The Decisive Battle in the US-Iran Conflict

Ava Grace|--

Meta's Latest Layoffs: Signal of Redundancy or AI Investment Returns?

Noah Lee|--

Senior US Official Resigns, Citing Israeli Pressure and False Threats as Motivation for Iran War

Liam James|--

Factors

Clinical Trial Results: Positive outcomes significantly increase the stock price, while negative results lead to a decrease. Regulatory Approvals: FDA approval of new therapies boosts investor confidence and the stock's value. Conversely, regulatory delays or rejections have a negative impact. Market Competition: The presence of competing drugs or therapies influences SRPT's market share and profitability, affecting its stock price. Financial Performance: Revenue growth, profitability, and cash flow impact investor sentiment and the stock's valuation. Overall Market Conditions: Broader economic trends and market sentiment can influence the trading activity and price of SRPT. Company-Specific News: Announcements regarding partnerships, acquisitions, or other strategic initiatives can move the stock price.

People Also Watch

Latest news

US Strategic Petroleum Reserve Release: Market Impact and Trader Strategies

Sophia Claire|--

US-Israel Alliance: Tactical Alignment, Strategic Divergence in the Iran Conflict

Liam James|--

Bank of Japan Navigates Oil Price Surge, Likely to Hold Rates Steady

Liam James|--

Latest Education Articles

Commodity CFDs explained: How to trade the price of gold (XAU) CFDs online in UAE?

Commodity CFDs explained: How to trade the price of gold (XAU) CFDs online in UAE?

Ghko B|--
Commodity Market Terms: What Are Basic Commdity Market Terms for Beginners in UAE?

Commodity Market Terms: What Are Basic Commdity Market Terms for Beginners in UAE?

Ghko B|--
How to trade top 3 cryptos in UAE: Bitcoin (BTC/USD), Ethereum (ETH/USD), Ripple (XRP/USD)?

How to trade top 3 cryptos in UAE: Bitcoin (BTC/USD), Ethereum (ETH/USD), Ripple (XRP/USD)?

Ghko B|--